Style | Citing Format |
---|---|
MLA | Moghtaderi M, et al.. "Retraction Note: Niosomes: A Novel Targeted Drug Delivery System for Cancer (Medical Oncology, (2022), 39, 12, (240), 10.1007/S12032-022-01836-3)." Medical Oncology, vol. 42, no. 5, 2025, pp. -. |
APA | Moghtaderi M, Sedaghatnia K, Bourbour M, Fatemizadeh M, Moghaddam ZS, Hejabi F, Heidari F, Quazi S, Far BF (2025). Retraction Note: Niosomes: A Novel Targeted Drug Delivery System for Cancer (Medical Oncology, (2022), 39, 12, (240), 10.1007/S12032-022-01836-3). Medical Oncology, 42(5), -. |
Chicago | Moghtaderi M, Sedaghatnia K, Bourbour M, Fatemizadeh M, Moghaddam ZS, Hejabi F, Heidari F, Quazi S, Far BF. "Retraction Note: Niosomes: A Novel Targeted Drug Delivery System for Cancer (Medical Oncology, (2022), 39, 12, (240), 10.1007/S12032-022-01836-3)." Medical Oncology 42, no. 5 (2025): -. |
Harvard | Moghtaderi M et al. (2025) 'Retraction Note: Niosomes: A Novel Targeted Drug Delivery System for Cancer (Medical Oncology, (2022), 39, 12, (240), 10.1007/S12032-022-01836-3)', Medical Oncology, 42(5), pp. -. |
Vancouver | Moghtaderi M, Sedaghatnia K, Bourbour M, Fatemizadeh M, Moghaddam ZS, Hejabi F, et al.. Retraction Note: Niosomes: A Novel Targeted Drug Delivery System for Cancer (Medical Oncology, (2022), 39, 12, (240), 10.1007/S12032-022-01836-3). Medical Oncology. 2025;42(5):-. |
BibTex | @article{ author = {Moghtaderi M and Sedaghatnia K and Bourbour M and Fatemizadeh M and Moghaddam ZS and Hejabi F and Heidari F and Quazi S and Far BF}, title = {Retraction Note: Niosomes: A Novel Targeted Drug Delivery System for Cancer (Medical Oncology, (2022), 39, 12, (240), 10.1007/S12032-022-01836-3)}, journal = {Medical Oncology}, volume = {42}, number = {5}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Moghtaderi M AU - Sedaghatnia K AU - Bourbour M AU - Fatemizadeh M AU - Moghaddam ZS AU - Hejabi F AU - Heidari F AU - Quazi S AU - Far BF TI - Retraction Note: Niosomes: A Novel Targeted Drug Delivery System for Cancer (Medical Oncology, (2022), 39, 12, (240), 10.1007/S12032-022-01836-3) JO - Medical Oncology VL - 42 IS - 5 SP - EP - PY - 2025 ER - |